Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_752d07ee6765329bb4fa3f931909c35d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba782d3b1fd168eab19dd7b0875942aa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-08 |
filingDate |
2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df0abd2d79b5e5f3e513018f3571589b |
publicationDate |
2003-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03011316-A1 |
titleOfInvention |
Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
abstract |
Novel compositions for the treatment of IRDS and ARDS are indicated which contain a selective COX-2 inhibitor, and/or a pharmaceutically acceptable salt thereof and lung surfactant. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289388-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008151235-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238664-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008151235-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008259768-B2 |
priorityDate |
2001-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |